Although these data indicate that TREM2+ macrophages positively correlate with patient-reported urinary symptoms via the IPSS, the question remains whether these cells drive BPH progression and subsequently worsen symptoms or are accumulating as a response, such as in an effort to resolve chronic inflammation. This evidence concerns the gene TREM2 and benign prostatic hyperplasia.